Skip to content

Clinical trials

Phase 4 Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 4 Clear all

166 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20036
20046
20053
20065
20074
20087
20095
20107
201112
20128
201316
20149
201510
20168
20176
20185
20197
20206
202110
20225
20234
20242
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed103
Terminated25
Unknown status14
Withdrawn8
Recruiting8
Active, not recruiting5
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals22
Biogen19
Hoffmann-La Roche4
Merck KGaA, Darmstadt, Germany4
Tehran University of Medical Sciences4
Bayer3
Brown, Theodore R., M.D., MPH3
Multiple Sclerosis Center of Northeastern New York3
Sanofi3
Teva Branded Pharmaceutical Products R&D, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis166
Multiple Sclerosis, Relapsing-Remitting33
Fatigue5
Recurrence5
Muscle Spasticity4
Demyelinating Diseases3
Multiple Sclerosis, Chronic Progressive3
Optic Neuritis3
Stroke3
Cognitive Dysfunction2

Trials

Showing 51 to 75 of 166. Each trial links to its page on Pharma Observatory.

66 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.